Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Eupraxia Pharmaceuticals Inc (EPRX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in thousands)

	12-2024	12-2023	12-2022	12-2021	12-2020
Assets
Current Assets
Cash & Cash Equivalents	33,101	19,342	18,226	16,386	118
Marketable Securities	N/A	N/A	0	7,066	N/A
Receivables	229	191	90	337	487
TOTAL	$34,437	$19,803	$18,551	$24,001	$893

Non-Current Assets
PPE Net	425	456	512	462	247
Other Non-Current Assets	81	7	2	25	0
TOTAL	$506	$463	$515	$487	$247

Total Assets	$34,942	$20,266	$19,066	$24,488	$1,140

Liabilities
Current Liabilities
Short Term Debt	N/A	10,399	79	74	9,816
Accrued Expenses	1,538	3,027	2,410	1,074	1,786
Other current liabilities	N/A	N/A	N/A	N/A	1,345
TOTAL	$3,103	$19,374	$3,052	$1,779	$17,678

Non-Current Liabilities
Long Term Debt	N/A	N/A	7,589	7,265	N/A
Other Non-Current Liabilities	1,566	1,324	1,099	654	651
TOTAL	$0	$0	$7,641	$7,373	$451

Total Liabilities	$3,103	$19,374	$10,693	$9,152	$18,129

Shareholders' Equity
Common Shares	116,360	92,914	68,035	63,303	18,662
Retained earnings	-131,004	-105,501	-71,799	-58,185	-40,150
Other shareholders' equity	-4,161	-2,707	0	0	0
TOTAL	$33,405	$2,216	$9,472	$15,989	$-16,633

Total Liabilities And Equity	$36,508	$21,590	$20,165	$25,141	$1,496